在基于单细胞和转录组分析的肝细胞癌中发现线粒体自机制和柏柏林治疗点
Shumin Wen1, Xiaofeng Cheng1, Zhangrong Zhu1
1Department of Oncology, Yibin Integrated Traditional Chinese and Western Medicine Hospital, Yinbin, Sichuan Province, China.
Naunyn-Schmiedeberg's archives of pharmacology
|October 30, 2025
概括
这项研究表明,柏柏林向线粒体自途径,以逆转肝细胞癌 (HCC) 的进展. 它确定了参与HCC的关键基因和途径,为这种流行癌症提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的全球性癌症,其进展与线粒体损伤通过不清楚的机制有关.
- 柏柏林是一种天然化合物,显示出抗瘤潜力,但它在调节HCC中线粒体自的作用需要进一步调查.
研究的目的:
- 阐明HCC进展的分子机制,重点关注线粒体自.
- 通过探索其干预机制,评估柏柏林作为HCC的潜在治疗剂.
- 为新的HCC治疗策略提供理论基础.
主要方法:
- 对GEO数据,单细胞测序和体外实验的综合分析.
- 选差异表达的基因和与自相关的基因,以识别HCC中的枢纽基因.
- 分析了瘤免疫微环境,并通过生物信息学验证了柏柏林的治疗标和机制.
主要成果:
- 鉴定了132个与自相关的HCC基因和20个关键基因,这些基因对自和自细胞形成至关重要.
- 揭示了HCC中Autophagy其他,Mitophagy动物和HIF-1信号通路的显著激活.
- 证明柏柏林通过向关键基因 (例如BECN1,PINK1,HIF1A) 和调节这些途径来逆转HCC细胞恶性病变.
结论:
- 线粒体自在HCC的发病过程中起着核心作用.
- 柏柏林通过调节线粒体自和相关信号通路来显示HCC的治疗潜力.
- 这项研究为肝细胞癌的分子类型和组合疗法奠定了基础.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


